Nanologica AB (publ) (STO:NICA)
Sweden · Delayed Price · Currency is SEK 0.8320
+0.1820 (28.00%)
May 21, 2026, 1:04 PM CET
Nanologica AB Market Cap
Nanologica AB has a market cap or net worth of 213.7 million as of May 21, 2026. Its market cap has increased by 96.63% in one year.
Market Cap
213.70M
Enterprise Value
231.62M
Revenue
109.18M
Ranking
n/a
PE Ratio
2.50
Stock Price
0.83
Market Cap Chart
Since October 30, 2015, Nanologica AB's market cap has increased from 73.54M to 213.70M, an increase of 190.58%. That is a compound annual growth rate of 10.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 213.70M | 210.03% |
| Dec 30, 2025 | 68.93M | -57.14% |
| Dec 30, 2024 | 160.81M | -57.22% |
| Dec 29, 2023 | 375.92M | 33.47% |
| Dec 30, 2022 | 281.66M | -27.01% |
| Dec 30, 2021 | 385.87M | 3.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 228.72M |
| Initiator Pharma | 210.15M |
| Xintela AB | 199.81M |
| Diamyd Medical AB | 181.64M |
| Active Biotech AB | 173.45M |
| AlzeCure Pharma AB | 160.88M |
| Elicera Therapeutics AB | 145.61M |
| Alligator Bioscience AB | 140.70M |